Re:Theranos' Highly-Anticipated Defense of Its Tech Is Calle...
by EpicEng on Tuesday August 02, 2016 @03:24PM
(#12212574)
Perhaps, if the test offers a strategic or tactical advantage. I work in biotech on FDA regulated devices and assays. Just throwing something out there doesn't mean it has sufficient clinical utility to reach volume, and the process is very expensive.
[ Parent
| on HN ]
There are no comments on this comment yet.